Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;517(1):182-194.
doi: 10.1134/S1607672924700893. Epub 2024 Jun 10.

Hyperleptinemia as a Marker of Various Phenotypes of Obesity and Overweight in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus

Affiliations

Hyperleptinemia as a Marker of Various Phenotypes of Obesity and Overweight in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus

L V Kondratyeva et al. Dokl Biochem Biophys. 2024 Aug.

Abstract

The objective of the study was to identify different phenotypes of overweight in women with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) based on body mass index (BMI) and serum leptin levels, as well as to determine the frequencies of various metabolic disorders, hypertension, and cardiovascular complications (CVCs) in individual phenotypes. The study included 50 women with RA and 46 with SLE aged 18 to 65 years without a history of diabetes and fasting hyperglycemia. In all patients, the concentration of leptin was determined by ELISA, the concentration of insulin was determined by electrochemiluminescence analysis, and the HOMA-IR index was calculated. Hyperleptinemia was diagnosed at leptin concentrations > 11.1 ng/mL; insulin resistance (IR), at HOMA-IR values ≥ 2.77. Three main phenotypes of overweight were distinguished: "classic" (BMI ≥ 25 kg/m2 + hyperleptinemia), "healthy" (BMI ≥ 25 kg/m2, without hyperleptinemia), "hidden" or "latent" (BMI < 25 kg/m2 + hyperleptinemia), as well as "normal weight" (BMI < 25 kg/m2, without hyperleptinemia). Patients with RA and SLE were similar in age (p = 0.4), disease duration (p = 0.2) and BMI (p = 0.5). Hyperleptinemia was found in 46% of women with RA and in 74% of women with SLE (p = 0.005), and IR was found in 10 and 22% of patients, respectively (p = 0.2). The "classic" phenotype of overweight was diagnosed in 30%, "healthy" in 8%, and "hidden" in 16% of cases with RA and in 44%, 0%, and 30% of cases with SLE, respectively. IR was found in 3% and hypertension in 6% of patients with "normal weight." With the "classic" phenotype, IR (29%) and hypertension (66%) were more common than with "normal weight" (p < 0.01 in all cases); with the "hidden" phenotype, significant differences were obtained only in hypertension frequency (45%; p = 0.0012), but not IR (18%). Three out of four women with a history of cardiovascular complications suffered from "classic" overweight, and one patient had a "normal weight." In women with SLE up to 65 years of age, the frequency of hyperleptinemia, but not IR, is higher than in patients with RA. In both diseases, the "classic" overweight phenotype is most common. In RA, a "hidden" phenotype was detected less often than in SLE, at the same time, a "healthy" phenotype is not characteristic of SLE. The frequency of metabolic disorders and hypertension is low with the "normal weight" and "healthy" phenotype, high with the "classic" phenotype, and intermediate with the "hidden" phenotype.

Keywords: HOMA-IR; body mass index; hyperleptinemia; insulin resistance; leptin; obesity; overweight; phenotypes; rheumatoid arthritis; systemic lupus erythematosus.

PubMed Disclaimer

Similar articles

References

REFERENCES

    1. Myasoedova, E., Crowson, C.S., Kremers, H.M., Roger, V.L., Fitz-Gibbon, P.D., Therneau, T.M., and Gabriel, Sh.E., Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease, Ann. Rheum. Dis., 2011, vol. 70, no. 3, pp. 482–487. https://doi.org/10.1136/ard.2010.135871 - DOI - PubMed
    1. Baker, J.F., Billig, E., Michaud, K., Ibrahim, S., Caplan, L., Cannon, G.W., Stokes, A., Majithia, V., and Mikuls, T.R., Weight loss, the obesity paradox, and the risk of death in rheumatoid arthritis, Arthritis Rheumatol., 2015, vol. 67, no. 7, pp. 1711–1717. https://doi.org/10.1002/art.39136 - DOI - PubMed - PMC
    1. Kremers, H.M., Nicola, P.J., Crowson, C.S., Ballman, K.V., and Gabriel, Sh.E., Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis, Arthritis Rheum., 2004, vol. 50, no. 11, pp. 3450–3457. https://doi.org/10.1002/art.20612 - DOI - PubMed
    1. Santos, M.J., Vinagre, F., Canas da Silva, J., Gil, V., and Fonseca, J.E., Body composition phenotypes in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of Caucasian female patients, Clin. Exp. Rheumatol., 2011, vol. 219, no. 3, pp. 470–476.
    1. Katz, P., Gregorich, S., Yazdany, J., Trupin, L., Julian, L., Yelin, E., and Criswell, L.A., Obesity and its measurement in a community-based sample of women with systemic lupus erythematosus, Arthritis Care Res. (Hoboken), 2011, vol. 63, no. 2, pp. 261–268. https://doi.org/10.1002/acr.20343 - DOI - PubMed

LinkOut - more resources